concept

APOE Ε4

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about APOE Ε4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

182Connections
2Hypotheses
3Analyses
50Outgoing
50Incoming
0Experiments
5Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameAPOE Ε4
Key Genes/ProteinsABCG1, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE, AMYLOID, AMYLOID-BETA
Related DiseasesAging, ALS, Alzheimer, Alzheimer's Disease, Anxiety
Related PathwaysAmyloid

Pathway Diagram

graph TD
    APOE__4["APOE Epsilon4"]
    style APOE__4 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
    APOE__4 -->|"risk_factor_for"| Alzheimer_s_Disease["Alzheimer's Disease"]
    APOE__4 -.->|"inhibits"| Neuroprotection["Neuroprotection"]
    APOE__4 -->|"upregulates"| STING([STING])
    APOE__4 -.->|"biomarker for"| Alzheimer["Alzheimer"]
    APOE__4 -.->|"biomarker for"| Neuroinflammation["Neuroinflammation"]
    APOE__4 -.->|"biomarker for"| ALS["ALS"]
    APOE__4 -.->|"biomarker for"| Inflammation["Inflammation"]
    APOE__4 -->|"activates"| Neurodegeneration["Neurodegeneration"]
    APOE__4 -->|"activates"| Dementia["Dementia"]
    NEUROINFLAMMATION([NEUROINFLAMMATION]) -.->|"biomarker for"| APOE__4
    CYTOKINES([CYTOKINES]) -.->|"biomarker for"| APOE__4
    IL9([IL9]) -.->|"biomarker for"| APOE__4
    PDGFRB([PDGFRB]) -.->|"biomarker for"| APOE__4
    AMYLOID([AMYLOID]) -.->|"biomarker for"| APOE__4
    NPTX1([NPTX1]) -.->|"biomarker for"| APOE__4
    CHI3L1([CHI3L1]) -.->|"biomarker for"| APOE__4
    AMYLOID_BETA([AMYLOID-BETA]) -.->|"biomarker for"| APOE__4
    INFLAMMATION([INFLAMMATION]) -.->|"biomarker for"| APOE__4
    NEFL([NEFL]) -.->|"biomarker for"| APOE__4

Outgoing (132)

TargetRelationTypeStr
Alzheimer's diseaseassociated_withdisease1.00
Alzheimer Diseaserisk_factor_fordisease0.95
amyloid-beta plaque depositionpromotesprocess0.93
Aβ aggregationcausesmechanism0.90
tau spreadingcausesmechanism0.90

Incoming (50)

SourceRelationTypeStr
ASTROCYTEassociated_withgene0.60
APOEassociated_withgene0.60
APOE4activatesgene0.60
PLCG2interacts_withgene0.60
DNAassociated_withgene0.60

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
APOE ε4 Drives Lipid Droplet Accumulation in a Unique Lipid- 0.685 Alzheimer disease APOE ε4 Lipid Metabolism Differences in
APOE ε4-driven microglial lipid handling as proximal driver 0.626 neurodegeneration Non-Neuronal Transcriptional Changes Pre

Mentioning Analyses (3)

Scientific analyses that reference this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.585

Statistical Fine-Mapping of AD GWAS Loci to Identify Causal Variants

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.380

Survival Analysis of AD Patient Cohorts: Prognostic Markers and Time-to-Dementia

neurodegeneration | 2026-04-16 | 3 hypotheses Top: 0.877

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (5)

Multi-agent debates referencing this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Which clinical, genetic, and biomarker features are independent prognostic marke

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Can Bayesian fine-mapping of the top 25 AD GWAS loci identify credible sets of c

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Does fine-mapping to median 3-variant credible sets provide sufficient resolutio

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Is a 3-marker prognostic index clinically actionable for MCI patients, or does t

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning APOE Ε4 in their description or question text

No additional research found